论文部分内容阅读
我国是一个12亿人口的大国,癌症的发病率和死亡率都较高,多数最终要发展到晚期。晚期癌症患者可有多种症状,但疼痛最常见,且使患者最为痛苦。对癌症疼痛,医生有责任采取各种措施缓解疼痛症状,WHO使用“三阶梯止痛治疗原则”,对严重疼痛患者,不能用第一、二阶梯药物达到止痛时,宜选用吗啡治疗。 1994年1～3月使用西南药业股份有限公司研制生产的盐酸吗啡控释片(MorphineHydrochlorid Extended-Release Tablet,MER),商品名美菲康片,用于46例癌症患者的止痛治疗,取得了一定的疗效。
China is a large country with a population of 1.2 billion. The incidence and mortality of cancer are high, and most of them will eventually reach the advanced stage. Patients with advanced cancer can have multiple symptoms, but the pain is most common and most painful to the patient. For cancer pain, doctors are responsible for taking various measures to relieve pain symptoms. The WHO uses the “three-step analgesic treatment principle”. When patients with severe pain cannot achieve pain relief with the first and second step drugs, morphine should be used. From January to March 1994, Morphine Hydrochlorid Extended-Release Tablet (MER) developed by Southwest Pharmaceutical Co., Ltd. was used as an analgesic treatment for 46 cancer patients. A certain effect.